
RonanRx Inc. YCアプリケーション
San Francisco
RonanRx Inc.はSummer 2026バッチでHealthcare企業としてY Combinatorを卒業しました。以下:会社の事業内容、創業者、そして実際のYCフォームで質問ごとに再構築されたYCへの応募内容。
- YCバッチ
- Summer 2026
- 業界
- Healthcare
- 所在地
- San Francisco
- チーム規模
- 5
- ステータス
- Active
- ローンチ済み
- 2026
創業者
Lloyd ArmbrustFounder/CEO
Emily ColmanFounder
RonanRx Inc.の事業内容
RonanRX is a full-stack pharmaceutical company, starting with personalized peptides and GLP-1s. In our first 10 weeks, we went from having no pharmacy to being licensed in 33 states. Since launch, we’ve grown 50% week over week. We manufacture the medications ourselves, sell directly to patients, and eliminate the layers of middlemen that make prescription drugs more expensive. What makes this possible is AI. Traditional pharmaceutical companies are built to manufacture one drug for millions of people. RonanRX is purpose-built to personalize treatment for each patient: different biology, different response, different dose. Patients come directly to RonanRX or through doctors using our platform. Every patient completes our medical intake, meets with a licensed doctor through our telehealth platform, and receives a personalized prescription when appropriate. From there, we manufacture the medication ourselves and deliver it directly to the patient. Labs, wearables, medical history, treatment response, and other health data feed back into the platform so doctors can continuously refine treatment over time. Before AI, doing this for every patient at scale was impossible. We didn't invent the demand we are seeing. 80 Million people are on a GLP-1 and millions more are using Peptides. We're building a better way to manufacture, personalize, prescribe, and deliver them. Our founders have built and exited multiple companies, raised more than $100M, built a $50M U.S. medical manufacturing business, and spent years developing peptide therapeutics at companies including Eli Lilly and AbbVie. We’re just getting started with peptides and GLP-1s. Next comes hormone therapy and the rest of personalized medicine.
RonanRx Inc.のYCアプリケーション、再構築済み
Y Combinator 申請
RonanRx Inc. 様、Summer 2026 バッチ。公開データから回答された、実際のフォームの質問。
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
RonanRx Inc.
Personalized peptides & GLP-1s, direct to patient.
We are building RonanRX, a pharmaceutical company focused on personalized peptides and GLP-1 medications. Patients complete an online medical intake, meet with a licensed doctor through our telehealth platform, and receive a tailored prescription. We manufacture the drugs ourselves and ship directly to the patient, taking care of every step from medical consultation to delivery. We use AI to make it possible to personalize treatments at scale and close the feedback loop between patient data and ongoing care.
We are based in San Francisco, CA and will continue to be based there after YC.
San Francisco is our home and it's where our team, facility, and network are already set up. It's also the best place for health tech and for building a telehealth company quickly.
よくある質問
RonanRx Inc.の実際のYCアプリケーションですか?
いいえ。Y Combinatorは提出されたアプリケーションを非公開にしています。これは再構築されたものです。実際のYCフォームの質問に、RonanRx Inc.の公開データ(ローンチノート、創業者経歴、製品説明)から回答しています。RonanRx Inc.のような会社がYCにどのようにアピールするかを示しており、彼らが提出したテキストではありません。
RonanRx Inc.はどのYCバッチに参加しましたか?
RonanRx Inc.はY CombinatorのSummer 2026バッチに参加しました。
RonanRx Inc.は誰によって設立されましたか?
RonanRx Inc.はLloyd Armbrust, Emily Colmanによって設立されました。
RonanRx Inc.は何をしていますか?
Full Stack Pharmaceutical Company for Personalized Peptides and GLP-1s
完全な再構築されたアプリケーションはどのように読めばよいですか?
無料のRound Fundedアカウントを作成してください。 RonanRx Inc.の26つの回答からなる完全なアプリケーションと、他のすべてのYCバッチはYC Insightsにあります。